OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors

[1]  J. Wolf,et al.  Different promoter affinities account for specificity in MYC-dependent gene regulation , 2016, eLife.

[2]  W. Huber,et al.  Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause , 2016, Cell.

[3]  M. Geyer,et al.  Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation. , 2016, Molecular cell.

[4]  A. Rosenwald,et al.  A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer. , 2015, Cancer cell.

[5]  Chih-Yang Wang,et al.  Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.

[6]  A. Sabò,et al.  MYC: connecting selective transcriptional control to global RNA production , 2015, Nature Reviews Cancer.

[7]  T. Tokuyasu,et al.  Differential Requirements for eIF4E Dose in Normal Development and Cancer , 2015, Cell.

[8]  E. Olejniczak,et al.  Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. , 2015, Molecular cell.

[9]  Charles Y. Lin,et al.  Taming of the beast: shaping Myc-dependent amplification. , 2015, Trends in cell biology.

[10]  Raluca Gordân,et al.  Sequence specificity incompletely defines the genome-wide occupancy of Myc , 2014, Genome Biology.

[11]  G. Evan,et al.  Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis , 2014, Nature Communications.

[12]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[13]  Marco J. Morelli,et al.  Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis , 2014, Nature.

[14]  D. Ruggero,et al.  Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer , 2014, Cell.

[15]  J. Zuber,et al.  An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.

[16]  R. Roden,et al.  A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. , 2013, Cancer cell.

[17]  G. Evan,et al.  Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. , 2013, Genes & development.

[18]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[19]  S. Lowe,et al.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. , 2012, Cancer cell.

[20]  D. Ruggero.  Translational control in cancer etiology. , 2012, Cold Spring Harbor perspectives in biology.

[21]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[22]  S. Chiang,et al.  An alternative import pathway of AIF to the mitochondria. , 2011, International journal of molecular medicine.

[23]  A. Trumpp,et al.  Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts , 2011, Oncogene.

[24]  G. Evan,et al.  The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy , 2011, PloS one.

[25]  Hui-Wen Chang,et al.  ATPase family AAA domain containing 3A is an anti-apoptotic factor and a secretion regulator of PSA in prostate cancer. , 2011, International journal of molecular medicine.

[26]  N. Wong,et al.  Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial‐to‐mesenchymal transition , 2011, Hepatology.

[27]  D. Hanahan,et al.  Endogenous Myc maintains the tumor microenvironment. , 2011, Genes & development.

[28]  A. Rosenwald,et al.  The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. , 2011, Molecular cell.

[29]  D. Felsher,et al.  The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance. , 2010, Genes & development.

[30]  S. Sugano,et al.  ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells , 2010, Journal of Cell Science.

[31]  H. Stein,et al.  Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. , 2010, Cancer cell.

[32]  J. Baudier,et al.  The AAA+ ATPase ATAD3A Controls Mitochondrial Dynamics at the Interface of the Inner and Outer Membranes , 2010, Molecular and Cellular Biology.

[33]  E. Mayatepek,et al.  C. elegans ATAD-3 Is Essential for Mitochondrial Activity and Development , 2009, PloS one.

[34]  I. Bernstein,et al.  Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. , 2008, Cell stem cell.

[35]  Davide Ruggero,et al.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.

[36]  G. Evan,et al.  Modelling Myc inhibition as a cancer therapy , 2008, Nature.

[37]  K. Zeller,et al.  Global Regulation of Nucleotide Biosynthetic Genes by c-Myc , 2008, PloS one.

[38]  Ivan Dikic,et al.  Proteasome subunit Rpn13 is a novel ubiquitin receptor , 2008, Nature.

[39]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[40]  E. Kremmer,et al.  Interdependence of Pes1, Bop1, and WDR12 Controls Nucleolar Localization and Assembly of the PeBoW Complex Required for Maturation of the 60S Ribosomal Subunit , 2007, Molecular and Cellular Biology.

[41]  E. Passegué,et al.  Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch , 2006, Proceedings of the National Academy of Sciences.

[42]  T. Frebourg,et al.  Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis , 2006, Genes, chromosomes & cancer.

[43]  Giacomo Finocchiaro,et al.  Myc-binding-site recognition in the human genome is determined by chromatin context , 2006, Nature Cell Biology.

[44]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Stephen K. Burley,et al.  X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors , 2003, Cell.

[46]  R. DePinho,et al.  Essential role for Max in early embryonic growth and development. , 2000, Genes & development.

[47]  M. Helmer-Citterich,et al.  Design and properties of a Myc derivative that efficiently homodimerizes , 1998, Oncogene.

[48]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[49]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[50]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[51]  H. Stein,et al.  Tumor Stroma-Derived TGF-b Limits Myc-Driven Lymphomagenesis via Suv 39 h 1-Dependent Senescence , 2009 .

[52]  Chi V. Dang,et al.  The interplay between MYC and HIF in cancer , 2008, Nature Reviews Cancer.